Winner Ebitda vs Cost Of Revenue Analysis

300888 Stock

35.20 0.10 0.28%

Winner Medical Co financial indicator trend analysis is more than just analyzing Winner Medical Co current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Winner Medical Co is a good investment. Please check the relationship between Winner Medical Co Ebitda and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Winner Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Winner Medical Co Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Winner Medical Co's Ebitda and Cost Of Revenue is 0.87. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Winner Medical Co, assuming nothing else is changed. The correlation between historical values of Winner Medical Co's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Winner Medical Co are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Winner Medical Co's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Winner Medical Co income statement and represents the costs associated with goods and services Winner Medical Co provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Winner Medical Co's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Winner Medical Co current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Winner Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 222.6 M, whereas Selling General Administrative is forecasted to decline to about 1.6 B.

	2021	2022	2023	2024 (projected)
Gross Profit	4.0B	5.4B	4.0B	3.9B
Total Revenue	8.0B	11.4B	8.2B	7.5B

Gross Profit Total Revenue

Winner Medical Co fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Non Current Liabilities Other	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Shares Outstanding
Total Assets		0.69	0.94	0.99	0.86	0.97	1.0	0.89	0.98	0.9	0.8	0.94	0.78	0.84	0.94	0.91	0.05	0.95	0.74	0.84	0.98	0.82	0.82	0.92	0.83	0.8
Other Current Liab	0.69		0.64	0.71	0.34	0.69	0.71	0.41	0.7	0.44	0.44	0.57	0.61	0.28	0.65	0.47	-0.31	0.62	0.45	0.59	0.75	0.48	0.32	0.39	0.27	0.14
Total Current Liabilities	0.94	0.64		0.89	0.87	0.84	0.92	0.92	0.88	0.96	0.73	0.88	0.67	0.81	0.86	0.95	0.31	1.0	0.65	0.81	0.89	0.74	0.89	0.84	0.85	0.75
Total Stockholder Equity	0.99	0.71	0.89		0.82	0.99	1.0	0.85	1.0	0.84	0.8	0.94	0.81	0.81	0.94	0.86	-0.08	0.9	0.75	0.82	1.0	0.82	0.76	0.92	0.78	0.78
Other Liab	0.86	0.34	0.87	0.82		0.78	0.84	0.86	0.82	0.89	0.68	0.8	0.62	0.96	0.78	0.87	0.41	0.88	0.61	0.7	0.8	0.76	0.98	0.9	0.98	0.87
Net Tangible Assets	0.97	0.69	0.84	0.99	0.78		0.98	0.83	0.99	0.8	0.8	0.93	0.81	0.78	0.93	0.83	-0.16	0.86	0.76	0.8	0.99	0.82	0.7	0.92	0.74	0.79
Retained Earnings	1.0	0.71	0.92	1.0	0.84	0.98		0.87	0.99	0.87	0.8	0.95	0.82	0.83	0.95	0.89	-0.03	0.93	0.77	0.85	0.99	0.83	0.78	0.91	0.8	0.77
Accounts Payable	0.89	0.41	0.92	0.85	0.86	0.83	0.87		0.83	0.94	0.82	0.94	0.72	0.84	0.88	0.98	0.28	0.93	0.78	0.74	0.82	0.83	0.86	0.9	0.89	0.87
Cash	0.98	0.7	0.88	1.0	0.82	0.99	0.99	0.83		0.83	0.79	0.91	0.77	0.8	0.92	0.83	-0.1	0.89	0.7	0.82	0.99	0.78	0.74	0.92	0.76	0.79
Non Current Assets Total	0.9	0.44	0.96	0.84	0.89	0.8	0.87	0.94	0.83		0.73	0.88	0.62	0.86	0.82	0.97	0.4	0.97	0.66	0.82	0.82	0.73	0.91	0.88	0.89	0.85
Non Currrent Assets Other	0.8	0.44	0.73	0.8	0.68	0.8	0.8	0.82	0.79	0.73		0.89	0.67	0.72	0.87	0.75	-0.14	0.75	0.76	0.8	0.78	0.73	0.64	0.77	0.73	0.68
Other Assets	0.94	0.57	0.88	0.94	0.8	0.93	0.95	0.94	0.91	0.88	0.89		0.86	0.83	0.98	0.93	-0.01	0.9	0.9	0.83	0.92	0.91	0.76	0.9	0.83	0.8
Net Receivables	0.78	0.61	0.67	0.81	0.62	0.81	0.82	0.72	0.77	0.62	0.67	0.86		0.71	0.92	0.74	-0.2	0.68	0.94	0.71	0.81	0.9	0.55	0.68	0.64	0.52
Non Current Liabilities Total	0.84	0.28	0.81	0.81	0.96	0.78	0.83	0.84	0.8	0.86	0.72	0.83	0.71		0.83	0.86	0.31	0.83	0.7	0.79	0.78	0.79	0.93	0.89	0.97	0.85
Inventory	0.94	0.65	0.86	0.94	0.78	0.93	0.95	0.88	0.92	0.82	0.87	0.98	0.92	0.83		0.88	-0.08	0.87	0.91	0.85	0.93	0.91	0.74	0.85	0.8	0.71
Other Current Assets	0.91	0.47	0.95	0.86	0.87	0.83	0.89	0.98	0.83	0.97	0.75	0.93	0.74	0.86	0.88		0.33	0.96	0.79	0.77	0.84	0.84	0.88	0.88	0.89	0.84
Other Stockholder Equity	0.05	-0.31	0.31	-0.08	0.41	-0.16	-0.03	0.28	-0.1	0.4	-0.14	-0.01	-0.2	0.31	-0.08	0.33		0.3	-0.12	-0.01	-0.1	0.03	0.55	0.13	0.44	0.27
Total Liab	0.95	0.62	1.0	0.9	0.88	0.86	0.93	0.93	0.89	0.97	0.75	0.9	0.68	0.83	0.87	0.96	0.3		0.67	0.83	0.89	0.75	0.89	0.86	0.87	0.77
Deferred Long Term Liab	0.74	0.45	0.65	0.75	0.61	0.76	0.77	0.78	0.7	0.66	0.76	0.9	0.94	0.7	0.91	0.79	-0.12	0.67		0.66	0.73	0.95	0.56	0.71	0.68	0.6
Short Long Term Debt	0.84	0.59	0.81	0.82	0.7	0.8	0.85	0.74	0.82	0.82	0.8	0.83	0.71	0.79	0.85	0.77	-0.01	0.83	0.66		0.81	0.62	0.69	0.71	0.72	0.58
Total Current Assets	0.98	0.75	0.89	1.0	0.8	0.99	0.99	0.82	0.99	0.82	0.78	0.92	0.81	0.78	0.93	0.84	-0.1	0.89	0.73	0.81		0.81	0.74	0.89	0.76	0.74
Non Current Liabilities Other	0.82	0.48	0.74	0.82	0.76	0.82	0.83	0.83	0.78	0.73	0.73	0.91	0.9	0.79	0.91	0.84	0.03	0.75	0.95	0.62	0.81		0.71	0.81	0.8	0.7
Intangible Assets	0.82	0.32	0.89	0.76	0.98	0.7	0.78	0.86	0.74	0.91	0.64	0.76	0.55	0.93	0.74	0.88	0.55	0.89	0.56	0.69	0.74	0.71		0.83	0.98	0.81
Common Stock	0.92	0.39	0.84	0.92	0.9	0.92	0.91	0.9	0.92	0.88	0.77	0.9	0.68	0.89	0.85	0.88	0.13	0.86	0.71	0.71	0.89	0.81	0.83		0.88	0.96
Property Plant Equipment	0.83	0.27	0.85	0.78	0.98	0.74	0.8	0.89	0.76	0.89	0.73	0.83	0.64	0.97	0.8	0.89	0.44	0.87	0.68	0.72	0.76	0.8	0.98	0.88		0.85
Common Stock Shares Outstanding	0.8	0.14	0.75	0.78	0.87	0.79	0.77	0.87	0.79	0.85	0.68	0.8	0.52	0.85	0.71	0.84	0.27	0.77	0.6	0.58	0.74	0.7	0.81	0.96	0.85

Click cells to compare fundamentals

Winner Medical Co Account Relationship Matchups

Winner Medical Co fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.5B	13.0B	13.3B	18.2B	17.1B	10.4B
Other Current Liab	205.5M	1.3B	816.2M	1.5B	19.7M	18.7M
Total Current Liabilities	1.2B	2.4B	2.1B	5.5B	4.3B	2.6B
Total Stockholder Equity	3.2B	10.5B	10.7B	11.7B	11.5B	7.4B
Other Liab	46.7M	107.1M	123.0M	241.0M	277.2M	291.1M
Net Tangible Assets	3.0B	10.2B	10.4B	9.6B	11.1B	6.2B
Retained Earnings	1.8B	5.5B	6.0B	7.2B	6.6B	4.1B
Accounts Payable	735.8M	756.0M	770.7M	1.1B	1.4B	904.7M
Cash	480.8M	4.2B	4.3B	4.5B	4.7B	2.7B
Non Current Assets Total	1.9B	2.0B	2.9B	6.1B	6.6B	3.3B
Non Currrent Assets Other	19.0M	63.8M	115.6M	83.5M	104.9M	77.1M
Other Assets	253.8M	328.3M	413.1M	422.0M	485.3M	309.5M
Net Receivables	1.0B	844.3M	1.1B	932.6M	768.6M	827.7M
Non Current Liabilities Total	180.9M	107.1M	504.8M	567.5M	730.7M	767.2M
Inventory	992.4M	1.2B	1.6B	1.6B	1.4B	1.2B
Other Current Assets	180.6M	159.2M	179.1M	348.3M	383.2M	213.7M
Other Stockholder Equity	44.6K	(1.1M)	(1.6M)	782.8K	704.5K	739.7K
Total Liab	1.4B	2.5B	2.6B	6.1B	5.0B	2.9B
Deferred Long Term Liab	165.5M	121.3M	174.8M	132.7M	152.6M	133.6M
Short Long Term Debt	294.6M	120M	150.1M	2.3B	1.5B	755.6M
Total Current Assets	2.7B	11.0B	10.3B	12.1B	10.6B	7.1B
Intangible Assets	131.7M	208.3M	265.7M	1.0B	995.2M	1.0B
Property Plant Equipment	1.5B	1.5B	2.2B	3.6B	4.1B	4.3B
Net Invested Capital	3.4B	10.6B	10.7B	14.0B	13.2B	9.0B
Net Working Capital	1.5B	8.6B	8.3B	6.6B	6.3B	5.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Winner Stock

Balance Sheet is a snapshot of the financial position of Winner Medical Co at a specified time, usually calculated after every quarter, six months, or one year. Winner Medical Co Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Winner Medical Co and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Winner currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Winner Ebitda vs Cost Of Revenue Analysis

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Cost Of Revenue

Winner Medical Co fundamental ratios Correlations

Winner Medical Co Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Winner Medical Co fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Winner Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Total Stockholder Equity
Cash	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets

Other Stockholder Equity	- 0.31	Other Current Liab
Other Stockholder Equity	- 0.2	Net Receivables
Other Stockholder Equity	- 0.16	Net Tangible Assets
Other Stockholder Equity	- 0.14	Non Currrent Assets Other
Deferred Long Term Liab	- 0.12	Other Stockholder Equity
Total Current Assets	- 0.1	Other Stockholder Equity